Emla and Humalog drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Emla (lidocaine; prilocaine) and Humalog (insulin lispro recombinant). Common drug interactions include nausea among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Emla and Humalog. It is created by eHealthMe based on reports of 90 people who take the same drugs from the FDA, and is updated regularly.

What is Emla?

Emla has active ingredients of lidocaine; prilocaine. eHealthMe is studying from 5,276 Emla users. Check the latest studies of Emla.

What is Humalog?

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.



On Jul, 27, 2026

90 people who take Emla and Humalog together, and have interactions are studied.

Emla and Humalog drug interactions.

What are the common drug interactions of Emla and Humalog, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Dyspnoea (difficult or laboured respiration)
  4. Headache (pain in head)
  5. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  6. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  7. Urinary retention (the inability to completely or partially empty the bladder)
  8. Actinomycosis (infection that causes sores, or abscesses)
  9. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  10. Arrhythmia (irregular heartbeat)

male:

  1. Renal failure (kidney dysfunction)
  2. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  3. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  4. Impaired work ability
  5. Nephrolithiasis (calculi in the kidneys)
  6. Renal impairment (severely reduced kidney function)
  7. Renal transplant
  8. Tooth loss
  9. Dyspnoea (difficult or laboured respiration)
  10. Nephrogenic anaemia (anaemia due to kidney disease)

What are the common drug interactions of Emla and Humalog, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  2. Abdominal pain
  3. Aspartate aminotransferase increased
  4. Autoimmune thyroiditis (form of thyroiditis associated with an autoimmune disease)
  5. Blood cholesterol increased
  6. Blood triglycerides increased
  7. Coagulopathy (blood's ability to clot is impaired)
  8. Cough
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Dehydration (dryness resulting from the removal of water)

20-29:

  1. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)

30-39:

  1. Abdominal pain upper
  2. Aphasia (damage to the parts of the brain that control language)
  3. Arthralgia (joint pain)
  4. Blood creatinine increased
  5. Blood glucose decreased
  6. Blood urea increased
  7. Chest discomfort
  8. Clumsiness (a lack of coordination or elegance)
  9. Constipation
  10. Dyspareunia (painful sexual intercourse)

40-49:

  1. Renal failure (kidney dysfunction)
  2. Cellulitis (infection under the skin)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Urinary tract infection
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  8. Decreased activity
  9. Emotional distress
  10. Hyperkalaemia (damage to or disease of the kidney)

50-59:

  1. Bone disorder
  2. Cachexia (loss of weight)
  3. Candidiasis (candidiasis or thrush is a fungal infection)
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Congestive cardiomyopathy (weakening of heart muscle)
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  7. Cough
  8. Dehydration (dryness resulting from the removal of water)
  9. Delirium (wild excitement)
  10. Dental caries

60+:

  1. Back pain
  2. Pneumonia
  3. Pyrexia (fever)
  4. Anaemia (lack of blood)
  5. Blood creatinine increased
  6. Blood pressure decreased
  7. Chronic kidney disease
  8. Colon cancer
  9. Death
  10. Haemophilus bacteraemia (bacterial infection by haemophilus influenzae)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 18 people, 20.00%
  2. Pain: 13 people, 14.44%
  3. Depression: 10 people, 11.11%
  4. Nausea And Vomiting: 9 people, 10.00%
  5. Diarrhea: 8 people, 8.89%
  6. Insomnia (sleeplessness): 8 people, 8.89%
  7. High Blood Pressure: 7 people, 7.78%
  8. Indigestion: 6 people, 6.67%
  9. Hypotension (abnormally low blood pressure): 6 people, 6.67%
  10. Haemorrhoids (a swollen vein or group of veins in the region of the anus): 6 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Emla and Humalog?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Emla and Humalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Emla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Humalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Emla and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Humalog and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lidocaine; prilocaine and insulin lispro recombinant (the active ingredients of Emla and Humalog, respectively), and Emla and Humalog (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: